Phio Pharmaceuticals Corp. (PHIO) stock
PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.72−0.04 (-4.65%)
Close on Nov 17, 2026Market cap $8.33MP/E –Yield –
Phio Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Phio Pharmaceuticals's revenue for the twelve months ending Dec 31, 2020 was $0, down 100.0% year over year. For fiscal 2020 it was $0, down 100.0% from the year before. The highest annual figure on record is $399.00K in fiscal 2013.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $0 | -100.0% |
| FY2019 | Dec 31, 2019 | $21.00K | -84.8% |
| FY2018 | Dec 31, 2018 | $138.00K | +820.0% |
| FY2017 | Dec 31, 2017 | $15.00K | -21.1% |
| FY2016 | Dec 31, 2016 | $19.00K | -44.1% |
| FY2015 | Dec 31, 2015 | $34.00K | -91.5% |
| FY2013 | Dec 31, 2013 | $399.00K | +311.3% |
| FY2012 | Dec 31, 2012 | $97.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2020 | Dec 31, 2020 | $0 | – |
| Q3 FY2020 | Sep 30, 2020 | $0 | – |
| Q2 FY2020 | Jun 30, 2020 | $0 | – |
| Q1 FY2020 | Mar 31, 2020 | $0 | -100.0% |
| Q4 FY2019 | Dec 31, 2019 | $0 | – |
| Q3 FY2019 | Sep 30, 2019 | $0 | -100.0% |
| Q2 FY2019 | Jun 30, 2019 | $0 | -100.0% |
| Q1 FY2019 | Mar 31, 2019 | $21.00K | -8.7% |
| Q4 FY2018 | Dec 31, 2018 | $0 | -100.0% |
| Q3 FY2018 | Sep 30, 2018 | $57.00K | – |
| Q2 FY2018 | Jun 30, 2018 | $58.00K | – |
| Q1 FY2018 | Mar 31, 2018 | $23.00K | – |
| Q4 FY2017 | Dec 31, 2017 | $15.00K | – |
| Q3 FY2017 | Sep 30, 2017 | $0 | – |
| Q2 FY2017 | Jun 30, 2017 | $0 | – |
| Q4 FY2016 | Dec 31, 2016 | $0 | – |
| Q3 FY2016 | Sep 30, 2016 | $0 | – |
See a number that looks wrong?